“Big data” has been in the news a lot lately. Where does all the information that gets funneled through our social media feeds actually get stored? And who is ever going to look at this stuff anyway? Great question in light of the fact that we are living in a world moving at warp speed…
Mobile phones are both a blessing and a curse. Why, you ask? Well, because they represent the paradox of modern day life—the illusion of being both “everywhere” and “nowhere” at the same time. Everywhere, because at the click of a button, we can be transported into our office, a discussion forum, an online working group, our…
Online social networks play important roles in how businesses establish contacts, improve processes, and maintain competitiveness. Unfortunately, they also tend to expose not only our positive professional attributes and successes, but also our scars and blemishes. This level of transparency leaves an indelible footprint in our digital ecosystem. It also imparts a feeling of continuous…
Email has certainly become run-of-the-mill since its inception circa 1972. Little did Ray Tomlinson, the man credited with inventing email, know that over 3.7 billion people would be emailing in 2018! The rise of email has had to do with our shared belief that it’s more efficient than face-to-face meetings and phone calls. Moreover, it has enabled information sharing…
In recent years, digital innovation has fundamentally transformed the pharmaceutical industry. Despite concerns about compliance and risk mitigation, the world of “digital” is rapidly infiltrating the way in which pharmaceutical, medical, scientific, market access, and marketing teams are communicating, collaborating and crowdsourcing new ideas. In short, we are seeing an unprecedented level of disruption. This disruption is the…
The impetus, Happy Holidays to you and your family from the Impetus Team and best wishes for the New Year….cheers!! View our video to see how we’re giving back this holiday season
Public scrutiny on healthcare costs, particularly drug costs, has been mounting over the past several years. Despite the validity of evidence supporting or naysaying the concerns about pricing and how drug costs fare versus other healthcare costs, public perception undoubtedly informs and creates reality. The perception that drug prices are increasing in countries like Canada…
There is a lot of excitement in the air about the use and further development of immunotherapies in Oncology. For many, this is a huge step change in the positive direction for how physicians will treat cancer patients in the future. There is much hope, despite some initial concerns about reduced efficacy in some patient…
What Is Indication-specific Pricing? Manufacturers have traditionally charged the same price for a drug regardless of the indication in question. With the new “indication-specific pricing” model, it is suggested that prices for a drug vary depending on the perceived “value/ benefit” of the drug in different indications. Source: 2015 ICER Membership Policy Summit Report…
Today, checkpoint inhibitor immuno-oncology (I-O) treatments are all the rage! Unlike traditional chemotherapies, I-O drugs enable a patient’s own immune system to identify and attack foreign cancer cells while leaving normal cells to continue to function unharmed. This is a huge opportunity to beef up cancer killing while maintaining the integrity of a patient’s quality…
